Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study

Qu, WF; Ding, ZB; Qu, XD; Tang, Z; Zhu, GQ; Fu, XT; Zhang, ZH; Zhang, X; Huang, A; Tang, M; Tian, MX; Jiang, XF; Huang, R; Tao, CY; Fang, Y; Gao, J; Wu, XL; Zhou, J; Fan, J; Liu, WR; Shi, YH

Liu, WR; Shi, YH (通讯作者)，Fudan Univ, Zhongshan Hosp, Dept Liver Surg, Liver Canc Inst, 180 FengLin Rd, Shanghai, Peoples R China.

BJS OPEN, 2022; 6 (5):

Abstract

Background Combination conversion therapies afforded curative surgery chance for initially unresectable hepatocellular carcinoma (uHCC). This study ai......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索